EURACTIV logo

Commission for more transparency on GMO decisions

13-04-2006 (updated: 05-11-2012 )

Languages: Français | Deutsch

The Commission has decided to bring more scientific consistency and transparency to the way EFSA approves and delivers its decisions on Genetically Modified Organisms (GMOs).

The Commission decided on 12 April 2006 to introduce practical changes to the EFSA’s GMO approval process so that the scientific consistency and transparency of its decisions on GMOs will be improved. The Commission invites the EFSA, for example, to fully co-operate with member states national scientific bodies and to provide them with a detailed justification in case it rejects scientific objections raised by the national authorities. The Commission is also set to reserve itself the right to suspend the authorisation procedure and refer back the question if a member state raises “important new scientific questions”, which are not fully adressed by the EFSA opinion.

Positions

The environmental NGOs immediately welcomed the Commission's intentions and Greenpeace Europe wants EFSA to be immediately subject to mandatory guidelines on how to evaluate the risks of GMOs. It also calls for suspension of the current authorisation process and for re-asssessment of EFSA's previous opinions on GMOs.

EuropaBio welcomes most of the Commission's proposals for improvements, except the one which is to give the Commission the right to suspend the authorisation procedure and refer back the question if a member state raises new scientific questions not fully adressed by the EFSA opinion. "I find this point very confusing and wonder how the Commission will do this 'in the existing legal framework', as it says it will," said Simon Barber from EuropaBio. "If EFSA's scientific safety assessment process is politicised, it will become worthless," he continued.

Background

The role of the European Food Safety Authority (EFSA) GMO authorisation procedure is to ensure that only GMOs which are safe for human and animal consumption and for release into the environment can be placed on the European market. Several EU member states, including Austria, the current holder of the rotating EU Presidency have, however, criticised EFSA of GMO bias and say it has approved GM products without proper research.

Further Reading

EU official documents

NGOs and Think-Tanks

EURACTIV's editorial content is independent from the views of our sponsors.

Languages: Français | Deutsch

Do you value EURACTIV’s reporting? We need your support.

Dear reader,

Now more than ever we need unbiased, expert information on how and why the European Union functions. This information should not be behind a paywall, and we remain committed to providing our content for free.

We know our readers value our reporting, and the outpouring of support we have received since the beginning of the crisis shows that our readers are willing to step up for the journalism that they trust and value. We are seeing record-breaking interest in our journalism as our pageviews have doubled in the last year. At the same time, readers support in the form of recurring monthly financial contributions provides continuous support for our work enabling us to innovate. 

We are more confident than ever in our role bridging media, policy, and the public. And we thank you for your support.

Your recurring monthly financial contributions help us innovate for the future. Please consider making a recurring contribution to EURACTIV Media Network for Europe.

Topics  

Subscribe to our newsletters

Subscribe
Contribute